Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Vaccine|October 6, 2001
Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunizationR GlueckEuropean Journal of Immunology|October 1, 1981
Modulation of concanavalin A-induced lymphocyte stimulation by human low-density lipoproteinsE R Waelti, R Glueck, M W HessJournal of Travel Medicine|November 27, 1999
Tolerance and immunogenicity of the simultaneous administration of virosome hepatitis A and yellow fever vaccinesP A Bovier, B Althaus, R Glueck, et al.Immunology Letters|July 1, 1982
Enhancement of formylmethionyl-leucyl-phenylalanine-induced directional locomotion of human neutrophils by serum low-density lipoproteinsA Naef, E R Waelti, R Glueck, et al.Journal of Medical Virology|October 12, 2002
Long-term immunogenicity of an inactivated virosome hepatitis A vaccineP A Bovier, J Bock, L Loutan, et al.Molecular Immunology|December 14, 2001
Perspectives: towards a peptide-based vaccine against hepatitis C virusI P Hunziker, R Zurbriggen, R Glueck, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1995
Immunogenicity of purified duck embryo rabies vaccine (Lyssavac-N) with use of the WHO-approved intradermal postexposure regimenP Khawplod, R Glueck, H Wilde, et al.Vaccine|April 1, 1995
Efficacy study of a new albumin-free human diploid cell rabies vaccine (Lyssavac-HDC, Berna) in 100 severely rabies-exposed Thai patientsH Wilde, R Glueck, P Khawplod, et al.Pageof 1